Abstract
Many family planning (FP) advocates are already pursuing increased choices and access to contraception for women and adolescent girls in their country. The introduction and scale-up of an easy-to-use injectable called subcutaneous DMPA (DMPA-SC, or Sayana® Press* ) can help advocates to realize many of their existing access goals. This includes advocacy efforts that advance their country’s FP2020 commitments and the Sustainable Development Goals—especially Goals 3 (good health and well-being) and 5 (gender equality).
